levetiracetam in sodium chloride (14789-220)

Drug Facts

Product Profile

Brand Name levetiracetam in sodium chloride

Generic Name levetiracetam

Labeler nexus pharmaceuticals llc

Dosage Form INJECTION

Routes

INTRAVENOUS

Active Ingredients

levetiracetam 10 mg/mL

Manufacturer

Nexus Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 14789-220

Product ID 14789-220_a8f5d5d3-7659-4b56-895c-d1f9c3e81973

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA213532

Listing Expiration 2026-12-31

Marketing Start 2020-07-20

Pharmacologic Class

Physiologic Effect

decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 14789220

Hyphenated Format 14789-220

Supplemental Identifiers

RxCUI

1193358 1193360 1193362

UPC

0314789330150 0314789110080 0314789330082 0314789220086

UNII

44YRR34555

NUI

N0000008486

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam in sodium chloride (source: ndc)

Generic Name levetiracetam (source: ndc)

Application Number ANDA213532 (source: ndc)

Routes

INTRAVENOUS

source: ndc

Resolved Composition

Strengths

10 mg/mL

source: ndc

Packaging

10 BAG in 1 CARTON (14789-220-10) / 100 mL in 1 BAG (14789-220-08)

source: ndc

Packages (1)

14789-220-10 10 BAG in 1 CARTON (14789-220-10) / 100 mL in 1 BAG (14789-220-08)

Ingredients (1)

levetiracetam (10 mg/mL)

Linked Drug Pages (1)

Levetiracetam in Sodium Chloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRAVENOUS"], "spl_id": "a8f5d5d3-7659-4b56-895c-d1f9c3e81973", "openfda": {"nui": ["N0000008486"], "upc": ["0314789330150", "0314789110080", "0314789330082", "0314789220086"], "unii": ["44YRR34555"], "rxcui": ["1193358", "1193360", "1193362"], "spl_set_id": ["ee014183-a857-457b-9573-0cc168e560f3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Nexus Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (14789-220-10)  / 100 mL in 1 BAG (14789-220-08)", "package_ndc": "14789-220-10", "marketing_start_date": "20200720"}], "brand_name": "Levetiracetam in Sodium Chloride", "product_id": "14789-220_a8f5d5d3-7659-4b56-895c-d1f9c3e81973", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "14789-220", "generic_name": "Levetiracetam", "labeler_name": "Nexus Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam in Sodium Chloride", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "10 mg/mL"}], "application_number": "ANDA213532", "marketing_category": "ANDA", "marketing_start_date": "20200720", "listing_expiration_date": "20261231"}